Chiral resolution and absolute configuration of the enantiomers of the psychoactive "designer drug" 3,4-methylenedioxypyrovalerone

Chirality

Volumn 27, Issue 4, 2015, Pages 287-293

  Suzuki, Masaki ^a   Deschamps, Jeffrey R ^b   Jacobson, Arthur E ^a   Rice, Kenner C ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NAVAL RESEARCH LABORATORY   (United States)

Author keywords

3,4 methylenedioxypyrovalerone (MDPV); bath salts; designer drug; euphoric stimulant; non chromatographic chiral resolution; synthesis

Indexed keywords

3,4 METHYLENEDIOXYPYROVALERONE; DESIGNER DRUG; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; 3,4-METHYLENEDIOXYPYROVALERONE; HYDROCHLORIC ACID; PYRROLIDINE DERIVATIVE;

ARTICLE; CHIRALITY; DRUG DETERMINATION; DRUG SYNTHESIS; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RACEMIC MIXTURE; ROOM TEMPERATURE; STEREOCHEMISTRY; X RAY DIFFRACTION; CHEMISTRY; ISOLATION AND PURIFICATION; STEREOISOMERISM;

BENZODIOXOLES; DESIGNER DRUGS; HYDROCHLORIC ACID; LIMIT OF DETECTION; PSYCHOTROPIC DRUGS; PYRROLIDINES; STEREOISOMERISM;

EID: 84924917164     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.22423     Document Type: Article

References (11)

1. Koppe H, Ludwig G, Wedel H, Zeile K,. 1-(3'4'-Methylenedioxyphenyl-2-pyrrolidinealkanones. US Patent 3,478,050, November 11, 1969
2. Baumann M, Partilla J, Lehner K, Thorndike E, Hoffman A,. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. Neuropsychopharmacology 2013; 38: 552-562.
3. Spiller HA, Ryan ML, Weston RG, Jansen J,. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin Toxicol 2011; 49: 499-505.
4. German CL, Fleckenstein AE, Hanson GR,. Bath salts and synthetic cathinones: An emerging designer drug phenomenon. Life Sci 2014; 97: 2-8.
5. Katz DP, Bhattacharya D, Bhattacharya S, Deruiter J, Clark CR, Suppiramaniam V, Dhanasekaran M,. Synthetic cathinones: "A khat and mouse game." Toxicol Lett 2014; 229 (2): 349-356.
6. Antonowicz JL, Metzger AK, Ramanujam SL,. Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases. Gen Hosp Psychiatry 2011; 33: 640.e5-640.e6.
7. Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Grabenauer M, Thomas BF, Marusich JA, Wegner S, Olive MF,. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol 2014; 19: 165-174.
8. Heffe W,. Die Stevens-umlagerung von allyl-phenacyl-ammoniumsalzen. Helv Chim Acta 1964; 47: 1289-1292.
9. Meltzer PC, Butler D, Deschamps JR, Madras BK,. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: A promising class of monoamine uptake inhibitors. J Med Chem 2006; 49: 1420-1432.
10. Echavarren AM, Stille JK,. Palladium-catalyzed carbonylative coupling of aryl triflates with organostannanes. J Am Chem Soc 1988; 110: 1557-1565.
11. Montzka TA, Pindell TL, Matiskella JD,. Substituted tartranilic acids. A new series of resolving acids. J Org Chem 1968; 33: 3993-3995.